Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Pfizer Inc. (PFE)’s Generic Split Buffers the Dow’s Falling Financials

The Dow Jones Industrial Average is kicking off the new week in the red as a disappointment from the flourishing housing sector pressures the markets. The blue-chip index is down 21 points as of 2:25 p.m. EDT, with most of its member stocks down for the day. The financial sector has borne the brunt of Wall Street’s blows so far, but one pharmaceutical standout is saving the Dow from worse losses. Let’s dive into the stories you need to know about today.

Pfizer Inc. (NYSE:PFE)A slight dip in housing takes down the banks
Pending home sales contracted 0.4% for June, according to a report today from the National Association of Realtors. Rising mortgage rates have tempted some observers and analysts to back off from the rapid housing boom that has taken over 2013, as pending home sales are still up more than 10% for the year despite June’s fall. Housing starts have done even better, gaining a whopping 24% year to date.

Still, financial stocks have fallen on the news, with Bank of America Corp (NYSE:BAC) leading the way downward as shares dip 1.1%. Bank of America Corp (NYSE:BAC)’s on the right side of the Dow for the year, with the stock up more than 27% year to date, and today’s drop isn’t a danger to the big bank. B of A’s mortgage department did show weakness last quarter, while its investment-banking unit led the way for the company’s earnings. However, so long as the housing market continues its overall rebound, B of A should be just fine.

Surprisingly, the contraction in housing data hasn’t hit shares of The Home Depot, Inc. (NYSE:HD) today, despite the big retailer’s close ties to the sector’s rebound. The company’s shares have surged on housing’s comeback, and caution regarding rising mortgage rates has helped slow that surge recently. The Home Depot, Inc. (NYSE:HD) has put space between itself and its closest competitor, fellow home-improvement retailer Lowe’s Companies, Inc. (NYSE:LOW), even as both companies steam forward behind housing’s bounce.

Today’s biggest story on the Dow isn’t about the housing market, however. Shares of big pharma Pfizer Inc. (NYSE:PFE) have jumped 1.8% to lead the sluggish index today after the company announced that it will split its generic- and branded-drug businesses into two operating segments. Pfizer Inc. (NYSE:PFE)’s branded-drug business, responsible for blockbuster successes like cholesterol-fighting Lipitor, has long been the firm’s growth driver, and it’s squarely in investors’ focus going forward.

What does the split mean? It could be the prelude to a spinoff of Pfizer Inc. (NYSE:PFE)’s generics business in the near future. The company’s leadership has consolidated operations recently, selling its infant nutrition business to Nestle last year in a nearly $12 billion sale. Pfizer Inc. (NYSE:PFE) then spun off its animal-health business, now Zoetis Inc (NYSE:ZTS), earlier in the year. While the divestments have turned Pfizer Inc. (NYSE:PFE) into a smaller, more concentrated firm, the high margins and strong growth from branded-pharmaceutical sales have this company’s future — and the stock’s future — looking bright.

Pfizer Inc. (NYSE:PFE)’s long-term approach to growth is a reminder of the most important maxim of investing: The best investing approach is to choose great companies and stick with them for the long term.

The article Pfizer’s Generic Split Buffers the Dow’s Falling Financials originally appeared on

Fool contributor Dan Carroll has no position in any stocks mentioned. The Motley Fool recommends Bank of America, Home Depot, and Lowe’s. The Motley Fool owns shares of Bank of America.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.